Elmiron Bellwether Trials To Start In 2023 And Focus on Blurred Vision

The judge has more than a year to analyze the testimony of experts that want to testify in upcoming Elmiron eye damage trials

Saturday, November 13, 2021 - Women who suffer from interstitial cystitis and are thinking about filing a lawsuit against Janssen Pharmaceutical and Johnson and Johnson will have to wait until early 2023 at the earliest before they receive a jury's reaction to the pertinent and credible testimony of expert witnesses that may prove taking Elmiron regularly, every day for years caused irreparable vision damage. If juries find that Janssen and Johnson & Johnson are responsible, and if large punitive damages are awarded, thousands of Elmiron vision loss victims are expected to come forward and file lawsuits. The lawsuits will try to hold the pharmaceutical conglomerates responsible for failing to warn them until too late. Women that have been taking Elmiron for more than one year and can show that they have been diagnosed with progressive pigmentary maculopathy should consult with an Elmiron eye damage lawyer to see if they have a case. Prospective plaintiffs must show that they have been prescribed Elmiron and have medical records showing they have a form of macular degeneration. Elmiron eye problems are progressive and continues to degenerate even if a patient stops taking the drug.

Interstitial cystitis (IC) is a medical condition also known as bladder pain syndrome, where the inner walls of the bladder are irritated. According to the Mayo Clinic, "interstitial cystitis may be mistaken for a urinary tract infection (UTI), but there is no infection. Symptoms include bladder and pelvic pain or pressure and a frequent urge to urinate. Painful bladder syndrome is often difficult to treat. Therapies may include medications, physical therapy, and biofeedback. Antibiotics haven't been shown to help with painful bladder syndrome." Some women who think they only have a UTI drink cranberry juice thinking it will help, but it only worsens the condition. Women who fear taking Elmiron or who find Elmiron ineffective resort to holistic medicine and dieting. Some people have reported positive results from receiving acupuncture treatment and taking super-concentrated Aloe Vera capsules. Most think all three treatments may control bladder pain while not putting their vision at risk as they would do if they took Elmiron. One should not discontinue taking Elmiron, and that those concerned about the drug's side effects should consult a physician.

More than 500 Elmiron eye lawsuits have been organized in multidistrict litigation under judge Brian Martinotti, in the District of New Jersey where the defendants are domiciled. 18 of the 25 plaintiff lawyers are women reflecting for the first time the makeup of plaintiffs being mostly women also. The plaintiff's attorneys were selected to give the pool "significant diversity in gender, ethnicity, geography, and experience," according to Law.com. Pigmentary maculopathy is when dark spots form on the retina at the back of the eye, making it difficult to read in less than optimal lighting conditions and impossible to drive at night. Elmiron plaintiffs allege that their occupation or job may have been compromised by their vision damage and many can not continue to work their job of choice because of poor vision. Many professions require an annual vision test to renew their professional license.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.